1. Prediction of pharmacokinetic alterations caused by drug-drug interactions: Metabolic interaction in the liver;Ito;Pharmacological Reviews,1998
2. Drug-drug interactions for UDP-glucuronosyltransferase substrates: A pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios;Williams;Drug Metabolism and Disposition,2004
3. FDA 2006 Guidance for Industry: Drug Interaction Studies- Study Design, Data Analysis, and Implications for Dosing and Labeling
4. FDA 2012 Guidance for Industry: Drug Interaction Studies- Study Design, Data Analysis, and Implications for Dosing and Labeling Recommendations
5. EMA 2012 European Medicines Agency: Guideline on the Investigation of Drug Interactions